RENAL RESEARCH INSTITUTE

A highly diverse
team imagining
the undiscovered

ABOUT THE RENAL RESEARCH INSTITUTE

The heart of RRI’s capacity for innovation is our ability to examine complex problems through multiple lenses.

The Renal Research Institute (RRI) is an internationally recognized incubator of ideas, treatment processes, and technologies to improve the lives of kidney patients. RRI’s leadership in computational biomedicine and data analytics, as well as our access to a large patient population, accelerates the pace of scientific discoveries and their translation into applied medicine. Our team includes some of the brightest minds from around the world, who, along with their disciplinary expertise, bring a deep understanding of global healthcare issues and challenges.

Jointly provided by Amedco, LLC & Columbia University

2022: Learn More

Jointly provided by Amedco, LLC & Columbia University

2022: Learn More 2021: VIEW PAST CONFERENCE

Celebrating 25 years

For 25 years Renal Research Institute has worked with the brightest minds in nephrology as a global incubator for the latest ideas, research, computational medicine, data analytics, technology and treatments that improves the lives of our patients living with chronic kidney disease. These 25 years of breakthrough science and advancements is truly a feat to celebrate, and worth recognizing , as we continue to try and make a positive difference in the lives of the people we serve.

Watch Celebration video

Our Research

RRI’s pioneering leadership in computational biomedicine and data analytics drives breakthroughs, including the introduction of virtual clinical trials and smartphone-based diagnostics. Not only does our interdisciplinary approach foster wide-ranging research within the global framework of Fresenius Medical Care, it encourages collaboration with academic institutions in the United States, Asia, Europe, Latin America, and Africa.

Latest Research & News

Displaying 1 articles

Latest Research
View All

Kidney Medicine Journal

May 14, 2023

Individualization of Serum-to-Dialysate Potassium Concentrat...

Jonathan S Chávez-Iñiguez, Jochen G Raimann

No abstract available

Displaying 1 articles

Latest News
View All

External Research

Mar 31, 2021

Introduction to Genomics of Kidney Disease Implications, Dis...

Matthew G. Sampson, Caroline S. Fox

In both clinical care and research, genetics and genomics are no longer solely in the domain of geneticists and basic science researchers. On the clinical side, there is expanding recognition of the utility of genetic testing in patients with kidney disease and an increased ability to order it. As such, the number of patients who...

Education

View All

Displaying 1 articles

LATEST EPISODE

Apr 27, 2022

Solutes, Scaling, Sex: are we getting the dosing of dialysis, right?

Join Dr. Peter Kotanko, MD, FASN, Head of Biomedical Evidence Generation and Renal Research Institute, and John Daugirdas, MD, FACP, FASN, Clinical Professor of Medicine at the University of Illinois School of Medicine at Chicago, as they discuss aspects around dialysis patient prescription.

Join Dr. Peter Kotanko, MD, FASN, Head of Biomedical Evidence Generation and Renal Research Institute, and John Daugirdas, MD, FACP, FASN, Clinical Professor of Medicine at the University of Illinois School of Medicine at Chicago, as they discuss aspects around dialysis patient prescription.